These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31186220)

  • 1. Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial.
    Chen S; Karmpaliotis D; Redfors B; Shlofmitz E; Ben-Yehuda O; Crowley A; Mehdipoor G; Puskas JD; Kandzari DE; Banning AP; Morice MC; Taggart DP; Sabik JF; Serruys PW; Kappetein AP; Stone GW
    EuroIntervention; 2019 Aug; 15(6):e531-e538. PubMed ID: 31186220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial.
    Chen S; Redfors B; Liu Y; Vrolix M; Macaya C; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Coron Artery Dis; 2019 Mar; 30(2):143-149. PubMed ID: 30531253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
    Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
    Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial.
    Kappetein AP; Serruys PW; Sabik JF; Leon MB; Taggart DP; Morice MC; Gersh BJ; Pocock SJ; Cohen DJ; Wallentin L; Ben-Yehuda O; van Es GA; Simonton CA; Stone GW
    EuroIntervention; 2016 Sep; 12(7):861-72. PubMed ID: 27639738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
    Milojevic M; Serruys PW; Sabik JF; Kandzari DE; Schampaert E; van Boven AJ; Horkay F; Ungi I; Mansour S; Banning AP; Taggart DP; Sabaté M; Gershlick AH; Bochenek A; Pomar J; Lembo NJ; Noiseux N; Puskas JD; Crowley A; Kosmidou I; Mehran R; Ben-Yehuda O; Généreux P; Pocock SJ; Simonton CA; Stone GW; Kappetein AP
    J Am Coll Cardiol; 2019 Apr; 73(13):1616-1628. PubMed ID: 30947913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
    Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
    J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: a post hoc analysis of the EXCEL trial.
    Thuijs DJFM; Habib RH; Head SJ; Puskas JD; Taggart DP; Stone GW; Zhang Z; Serruys PW; Sabik JF; Kappetein AP
    EuroIntervention; 2020 May; 16(1):36-43. PubMed ID: 31422924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.
    Gershlick AH; Kandzari DE; Banning A; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning AP; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Dressler O; Sabik JF; Serruys PW; Kappetein AP; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1224-1233. PubMed ID: 29976358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial).
    Kosmidou I; Crowley A; Macedo L; Ben-Yehuda O; Gersh BJ; Boonstra PW; Kappetein AP; Serruys PW; Sabik JF; Stone GW
    Am J Cardiol; 2020 Jan; 125(2):169-175. PubMed ID: 31735328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
    Kosmidou I; Redfors B; Chen S; Crowley A; Lembo NJ; Karmpaliotis D; Brown WM; Maupas E; Durrleman N; Shah A; Reardon MJ; Dressler O; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Am Heart J; 2019 Apr; 210():49-57. PubMed ID: 30738244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes After Left Main Coronary Artery Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting According to Smoking Status.
    Shahim B; Redfors B; Chen S; Morice MC; Gersh BJ; Puskas JD; Kandzari DE; Merkely B; Horkay F; Crowley A; Serruys PW; Kappetein AP; Sabik JF; Ben-Yehuda O; Stone GW
    Am J Cardiol; 2020 Jul; 127():16-24. PubMed ID: 32360038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.
    Huang X; Redfors B; Chen S; Liu Y; Ben-Yehuda O; Puskas JD; Kandzari DE; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Sabik JF; Serruys PW; Kappetein AP; Stone GW
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1144-1151. PubMed ID: 30596978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Mäkikallio T; Holm NR; Lindsay M; Spence MS; Erglis A; Menown IB; Trovik T; Eskola M; Romppanen H; Kellerth T; Ravkilde J; Jensen LO; Kalinauskas G; Linder RB; Pentikainen M; Hervold A; Banning A; Zaman A; Cotton J; Eriksen E; Margus S; Sørensen HT; Nielsen PH; Niemelä M; Kervinen K; Lassen JF; Maeng M; Oldroyd K; Berg G; Walsh SJ; Hanratty CG; Kumsars I; Stradins P; Steigen TK; Fröbert O; Graham AN; Endresen PC; Corbascio M; Kajander O; Trivedi U; Hartikainen J; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2016 Dec; 388(10061):2743-2752. PubMed ID: 27810312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.